Canature Health Technology Co., Ltd. (SHE:300272)
China
· Delayed Price · Currency is CNY 7.76
+0.01 (0.13%)
Mar 9, 2026, 3:04 PM CST
SHE:300272 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,745 | 3,475 | 3,483 | 2,949 | 4,078 | 2,948 | Upgrade
|
| Market Cap Growth | 38.57% | -0.21% | 18.08% | -27.68% | 38.34% | 3.61% | Upgrade
|
| Enterprise Value | 4,772 | 3,639 | 3,464 | 3,090 | 4,321 | 3,103 | Upgrade
|
| Last Close Price | 7.76 | 6.00 | 5.76 | 4.75 | 6.44 | 4.55 | Upgrade
|
| PE Ratio | 46.61 | 41.58 | 26.29 | 31.86 | 38.89 | 111.59 | Upgrade
|
| Forward PE | - | 27.50 | 27.50 | 27.50 | 27.50 | 27.50 | Upgrade
|
| PS Ratio | 2.65 | 2.06 | 2.08 | 1.78 | 2.70 | 2.50 | Upgrade
|
| PB Ratio | 3.06 | 2.65 | 2.54 | 2.64 | 3.26 | 2.42 | Upgrade
|
| P/TBV Ratio | 3.95 | 3.53 | 3.32 | 3.64 | 4.55 | 3.33 | Upgrade
|
| P/FCF Ratio | 36.36 | 18.29 | 11.82 | 48.47 | 35.31 | 30.30 | Upgrade
|
| P/OCF Ratio | 17.36 | 12.00 | 9.29 | 18.98 | 21.83 | 20.99 | Upgrade
|
| EV/Sales Ratio | 2.67 | 2.15 | 2.07 | 1.86 | 2.86 | 2.63 | Upgrade
|
| EV/EBITDA Ratio | 17.89 | 17.49 | 16.59 | 17.00 | 23.56 | 16.47 | Upgrade
|
| EV/EBIT Ratio | 24.33 | 22.65 | 21.81 | 23.94 | 30.78 | 20.54 | Upgrade
|
| EV/FCF Ratio | 36.57 | 19.15 | 11.76 | 50.77 | 37.41 | 31.90 | Upgrade
|
| Debt / Equity Ratio | 0.57 | 0.72 | 0.69 | 0.50 | 0.25 | 0.21 | Upgrade
|
| Debt / EBITDA Ratio | 3.32 | 4.06 | 4.03 | 2.75 | 1.63 | 1.35 | Upgrade
|
| Debt / FCF Ratio | 6.78 | 4.99 | 3.23 | 9.27 | 2.72 | 2.61 | Upgrade
|
| Net Debt / Equity Ratio | -0.05 | 0.12 | 0.04 | 0.14 | 0.03 | 0.06 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.35 | 0.74 | 0.27 | 0.83 | 0.18 | 0.41 | Upgrade
|
| Net Debt / FCF Ratio | -0.65 | 0.82 | 0.19 | 2.48 | 0.28 | 0.78 | Upgrade
|
| Asset Turnover | 0.57 | 0.57 | 0.63 | 0.74 | 0.77 | 0.62 | Upgrade
|
| Inventory Turnover | 3.91 | 4.14 | 3.70 | 3.62 | 4.07 | 3.44 | Upgrade
|
| Quick Ratio | 0.92 | 0.95 | 0.98 | 0.74 | 0.89 | 0.93 | Upgrade
|
| Current Ratio | 1.18 | 1.20 | 1.22 | 1.12 | 1.31 | 1.39 | Upgrade
|
| Return on Equity (ROE) | 8.53% | 8.46% | 12.33% | 8.36% | 9.49% | 4.13% | Upgrade
|
| Return on Assets (ROA) | 3.92% | 3.37% | 3.72% | 3.61% | 4.44% | 4.98% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.09% | 9.34% | 11.39% | 8.76% | 8.77% | 8.79% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.30% | 8.70% | 8.60% | 9.00% | 10.20% | 11.40% | Upgrade
|
| Earnings Yield | 2.00% | 2.40% | 3.80% | 3.14% | 2.57% | 0.90% | Upgrade
|
| FCF Yield | 2.75% | 5.47% | 8.46% | 2.06% | 2.83% | 3.30% | Upgrade
|
| Dividend Yield | 2.19% | 2.67% | 1.74% | 2.10% | 1.55% | 1.10% | Upgrade
|
| Payout Ratio | 142.42% | 217.13% | 59.01% | 75.48% | 38.97% | 159.81% | Upgrade
|
| Buyback Yield / Dilution | 4.51% | -1.03% | -1.19% | 2.82% | -10.26% | 10.64% | Upgrade
|
| Total Shareholder Return | 6.70% | 1.64% | 0.55% | 4.92% | -8.71% | 11.74% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.